These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 16689976

  • 41. Involution of the parathyroid glands after renal transplantation.
    Lewin E.
    Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):363-71. PubMed ID: 12815332
    [Abstract] [Full Text] [Related]

  • 42. Prevention of uremic bone disease using calcimimetic compounds.
    Olgaard K, Lewin E.
    Annu Rev Med; 2001 Jul; 52():203-20. PubMed ID: 11160775
    [Abstract] [Full Text] [Related]

  • 43. Increased parathyroid expression of klotho in uremic rats.
    Hofman-Bang J, Martuseviciene G, Santini MA, Olgaard K, Lewin E.
    Kidney Int; 2010 Dec; 78(11):1119-27. PubMed ID: 20631679
    [Abstract] [Full Text] [Related]

  • 44. Calcium and phosphorus metabolism in chronic uremia.
    Fiaschi E, Mioni G, Maschio G, D'Angelo A, Ossi E.
    Nephron; 1975 Dec; 14(2):163-80. PubMed ID: 1093055
    [Abstract] [Full Text] [Related]

  • 45. Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism.
    Välimäki S, Farnebo F, Forsberg L, Larsson C, Farnebo LO.
    Kidney Int; 2001 Nov; 60(5):1666-75. PubMed ID: 11703583
    [Abstract] [Full Text] [Related]

  • 46. Nutritional secondary hyperparathyroidism in rabbits.
    Bas S, Bas A, López I, Estepa JC, Rodríguez M, Aguilera-Tejero E.
    Domest Anim Endocrinol; 2005 May; 28(4):380-90. PubMed ID: 15826773
    [Abstract] [Full Text] [Related]

  • 47. Female hemodialysis patients have an increased risk of nodular hyperplasia of parathyroid glands.
    Lomonte C, Cazzato F, Casucci F, Chimienti D, Bruno A, Cocola S, Verrelli EA, Basile C.
    J Nephrol; 2005 May; 18(1):92-5. PubMed ID: 15772929
    [Abstract] [Full Text] [Related]

  • 48. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.
    Tominaga Y, Tsuzuki T, Uchida K, Haba T, Otsuka S, Ichimori T, Yamada K, Numano M, Tanaka Y, Takagi H.
    Kidney Int; 1999 Apr; 55(4):1375-83. PubMed ID: 10201002
    [Abstract] [Full Text] [Related]

  • 49. A role for enhanced integrin and FAK expression in uremia-induced parathyroid hyperplasia.
    Arcidiacono MV, Cozzolino M, Brancaccio D, Gallieni M, Lesma E, Carelli S, Gorio A, Di Giulio AM.
    J Nephrol; 2007 Apr; 20(2):228-33. PubMed ID: 17514628
    [Abstract] [Full Text] [Related]

  • 50. The role of phosphorus in the development of secondary hyperparathyroidism and parathyroid cell proliferation in chronic renal failure.
    Slatopolsky E, Dusso A, Brown AJ.
    Am J Med Sci; 1999 Jun; 317(6):370-6. PubMed ID: 10372836
    [Abstract] [Full Text] [Related]

  • 51. Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism.
    Tokumoto M, Tsuruya K, Fukuda K, Kanai H, Kuroki S, Hirakata H.
    Kidney Int; 2002 Oct; 62(4):1196-207. PubMed ID: 12234290
    [Abstract] [Full Text] [Related]

  • 52. FGF23 fails to inhibit uremic parathyroid glands.
    Canalejo R, Canalejo A, Martinez-Moreno JM, Rodriguez-Ortiz ME, Estepa JC, Mendoza FJ, Munoz-Castaneda JR, Shalhoub V, Almaden Y, Rodriguez M.
    J Am Soc Nephrol; 2010 Jul; 21(7):1125-35. PubMed ID: 20431039
    [Abstract] [Full Text] [Related]

  • 53. Function in athymic nude mice of parathyroid heterografts from patients with primary hyperparathyroidism and secondary hyperparathyroidism.
    Schachter P, Christy MD, Leight GS, Lobaugh B.
    Surgery; 1990 Dec; 108(6):1040-6. PubMed ID: 2247828
    [Abstract] [Full Text] [Related]

  • 54. Decreased expression of calcium receptor in parathyroid tissue in patients with hyperparathyroidism secondary to chronic renal failure.
    Martín-Salvago M, Villar-Rodríguez JL, Palma-Alvarez A, Beato-Moreno A, Galera-Davidson H.
    Endocr Pathol; 2003 Dec; 14(1):61-70. PubMed ID: 12746564
    [Abstract] [Full Text] [Related]

  • 55. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats.
    Román-García P, Carrillo-López N, Naves-Díaz M, Rodríguez I, Ortiz A, Cannata-Andía JB.
    Endocrinology; 2012 Apr; 153(4):1627-37. PubMed ID: 22334717
    [Abstract] [Full Text] [Related]

  • 56. Parathyroid-specific deletion of dicer-dependent microRNAs abrogates the response of the parathyroid to acute and chronic hypocalcemia and uremia.
    Shilo V, Ben-Dov IZ, Nechama M, Silver J, Naveh-Many T.
    FASEB J; 2015 Sep; 29(9):3964-76. PubMed ID: 26054367
    [Abstract] [Full Text] [Related]

  • 57. Role of multifunctional cell cycle modulators in advanced secondary hyperparathyroidism.
    Sato T, Kikkawa Y, Hiramitsu T, Yamamoto T, Goto N, Matsuoka S, Nagasaka T, Watarai Y, Uchida K, Tominaga Y.
    Ther Apher Dial; 2011 Jun; 15 Suppl 1():26-32. PubMed ID: 21595849
    [Abstract] [Full Text] [Related]

  • 58. Vitamin D receptor ligand therapy in chronic kidney disease.
    Gonzalez E.
    Clin Nephrol; 2008 Oct; 70(4):271-83. PubMed ID: 18826852
    [Abstract] [Full Text] [Related]

  • 59. Surgical management of secondary hyperparathyroidism in uremia.
    Tominaga Y.
    Am J Med Sci; 1999 Jun; 317(6):390-7. PubMed ID: 10372839
    [Abstract] [Full Text] [Related]

  • 60. Co-expression of parathyroid hormone and chromogranin A in secondary hyperparathyroidism: a functional marker for secretory activity of hyperplastic nodules.
    Tanaka R, Umemura S, Kakuta T, Fujisaki T, Sakai H, Saitoh A, Osamura RY.
    Pathol Res Pract; 2003 Jun; 199(2):93-9. PubMed ID: 12747471
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.